Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Classical hematology 1Breast 1

Conditions

Ovarian Neoplasms 1Neoplasms 1Genetic Predisposition to Disease 1Fanconi Anemia, Complementation Group D1 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

olaparib 9Carboplatin 3talazoparib 1pembrolizumab 1liposomal doxorubicin 1iniparib 1Trabectedin 1Surveys and Questionnaires 1Secretin 1Paclitaxel 1Genotype 1Genetic Counseling 1Demography 1Data Collection 1Counseling 1Cognitive Behavioral Therapy 1Biopsy, Fine-Needle 1ABT-767 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fanconi Anemia, Complementation Group D1 × Cognitive Behavioral Therapy × Classical hematology × Clear all
NCT03889171 2019-03-28

PSICOM

University Hospital, Montpellier

Completed
200 enrolled
BreastClassical hematologyGastrointestinalGynecologic

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms, Genetic Predisposition to Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡